GlassScriptPhysician profile
Brian L Henry
NPI 1629047824
$1,538.61
in general payments reported to CMS, 2019-2025
27 companies · $77.09 in 2025
The $77.09 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $196 · 2021: $166 · 2022: $399 · 2023: $137 · 2024: $19.93 · 2025: $77.09.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $234.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $234.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $332.95 | 2019-2023 | Xarelto |
| Bayer Healthcare Pharmaceuticals INC. | $125.91 | 2022-2025 | |
| Novo Nordisk INC | $113.85 | 2021-2025 | Wegovy |
| Amgen INC. | $101.58 | 2019-2023 | Repatha, Otezla |
| Boston Scientific Corporation | $89.91 | 2020-2022 | |
| Astrazeneca Pharmaceuticals LP | $85.79 | 2019 | |
| Astellas Pharma US INC | $76.97 | 2019 | |
| Abbvie INC. | $76.33 | 2019-2022 | |
| Glaxosmithkline, LLC. | $66.56 | 2019-2024 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $60.21 | 2019-2022 | |
| Pfizer INC. | $58.67 | 2019-2022 | |
| Sanofi Pasteur INC. | $52.92 | 2019-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $38.30 | 2022 | |
| Allergan, INC. | $28.72 | 2020 | |
| Ultragenyx Pharmaceutical INC. | $24.37 | 2023 | Crysvita |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $23.77 | 2022 | |
| Shield Therapeutics INC | $21.39 | 2023 | Accrufer |
| Sunovion Pharmaceuticals INC. | $19.66 | 2022 | |
| Esperion Therapeutics, INC. | $18.90 | 2021 | |
| Radius Health, INC. | $18.80 | 2020 | |
| Edwards Lifesciences Corporation | $16.81 | 2023 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Amarin Pharma, INC. | $16.34 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.47 | 2019 | |
| Seqirus USA INC | $15.42 | 2020 | |
| Medtronic, INC. | $14.74 | 2021 | |
| Novartis Pharmaceuticals Corporation | $14.29 | 2023 | |
| Bardy Diagnostics, INC. | $9.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Henry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.